Literature DB >> 22011801

Asymptomatic coronary artery disease in chagasic patients with heart failure: prevalence and risk factors .

Gustavo Carvalho1, Salvador Rassi, José Maria Dias de Azeredo Bastos, Sílvio Sérgio Pontes Câmara.   

Abstract

BACKGROUND: Concomitant asymptomatic coronary artery disease in patients with Chagas cardiomyopathy in heart failure is controversial in the medical literature, as both diseases are prevalent in some regions of Brazil.
OBJECTIVE: To determine the prevalence of coronary artery disease (lesions > 50%) in a specific population of patients with Chagas cardiomyopathy in HF functional class III and IV, who had no previous coronary events.
METHODS: Coronary angiography was performed in 61 consecutive patients with Chagasic cardiomyopathy, in heart failure functional class III and IV, to exclude coronary artery disease. These patients were part of the Cell Therapy Study in Heart Diseases protocol, which required the coronary angiography to be carried out before stem cells were injected. Risk factors for atherosclerosis also analyzed in this population were: age, arterial hypertension, diabetes, dyslipidemia, smoking and overweight.
RESULTS: mean age was 51.6 + 9.6 years and 65.5% (n = 40) of them were males. The prevalence of coronary disease in this population was 1.6% (1). The prevalence of risk factors were: arterial hypertension 18% (11), smoking 59% (36), diabetes 1.6% (1) and dyslipidemia, 6.5% (4).
CONCLUSION: The prevalence of asymptomatic coronary artery disease in patients with severe heart failure due to Chagas disease is low and among the risk factors for coronary heart disease, smoking was the most prevalent.

Entities:  

Mesh:

Year:  2011        PMID: 22011801     DOI: 10.1590/s0066-782x2011005000103

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  9 in total

1.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

Review 2.  Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger.

Authors:  Reinaldo Bulgarelli Bestetti; Edimar Alcides Bocchi; Renato Bestetti; Victor Sarli Issa; Rosemary Aparecida Furlan-Daniel; Marcelo Arruda Nakazone
Journal:  Front Med (Lausanne)       Date:  2022-06-29

3.  Chagasic cardiomyopathy and Pompe disease: case report.

Authors:  Rafael Ob de Morais; Ândrea V Chaves-Markman; Anna Pp Miranda; Ingrid G Amorim; Maria da Ga de M Cavalcanti; Manuel Markman; Brivaldo Markman-Filho
Journal:  Am J Cardiovasc Dis       Date:  2018-04-05

4.  Relationship between fibrosis and ventricular arrhythmias in Chagas heart disease without ventricular dysfunction.

Authors:  Eduardo Marinho Tassi; Marcelo Abramoff Continentino; Emília Matos do Nascimento; Basílio de Bragança Pereira; Roberto Coury Pedrosa
Journal:  Arq Bras Cardiol       Date:  2014-05-09       Impact factor: 2.000

5.  Dobutamine Stress Echocardiography Safety in Chagas Disease Patients.

Authors:  Daniela do Carmo Rassi; Marcelo Luiz Campos Vieira; Rogerio Gomes Furtado; Fabio de Paula Turco; Luciano Henrique Melato; Viviane Tiemi Hotta; Colandy Godoy de Oliveira Nunes; Luiz Rassi; Salvador Rassi
Journal:  Arq Bras Cardiol       Date:  2017-01-16       Impact factor: 2.000

Review 6.  Modulation of paraoxonases during infectious diseases and its potential impact on atherosclerosis.

Authors:  Ayman Samir Farid; Yoichiro Horii
Journal:  Lipids Health Dis       Date:  2012-07-23       Impact factor: 3.876

7.  The metabogenic role of iron in chronic chagasic cardiac failure.

Authors:  Carla Paixão Miranda; Fernando Antônio Botoni; Maria do Carmo Pereira Nunes; Manoel Ótavio da Costa Rocha
Journal:  Mem Inst Oswaldo Cruz       Date:  2015-02-03       Impact factor: 2.743

8.  Lower Prevalence and Severity of Coronary Atherosclerosis in Chronic Chagas' Disease by Coronary Computed Tomography Angiography.

Authors:  Savio Cardoso; Clerio Francisco de Azevedo Filho; Fábio Fernandes; Barbara Ianni; Jorge Andion Torreão; Mateus Diniz Marques; Luiz Francisco Rodrigues de Ávila; Raul Santos Filho; Charles Mady; Roberto Kalil-Filho; José Antônio Franchine Ramires; Marcio Sommer Bittencourt; Carlos E Rochitte
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

9.  Angiotensin-Converting Enzyme ID Polymorphism in Patients with Heart Failure Secondary to Chagas Disease.

Authors:  Silene Jacinto da Silva; Salvador Rassi; Alexandre da Costa Pereira
Journal:  Arq Bras Cardiol       Date:  2017-09-28       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.